Ireland Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Exotic travel ideas. Searching for your next vacation destination? Subscribe to Off The Beaten Path, a newsletter featuring captivating locales to help you to plan your next trip. From our sponsors

Ireland Pharmaceuticals and Healthcare Report Q4 2013 Oct 2nd 2013, 00:00, by swapnil BMI View: A number of negative developments this quarter have led us to downgrade our pharmaceutical and healthcare forecasts. The establishment of a ‘preferred drugs’ list and implementation of the Health (Pricing and Supply of Medical Goods) Bill shows the government’s determination to exact cost savings from pharmaceutical companies. While these initiatives will benefit generic drugmakers, the Irish Pharmacy Union has voiced concerns that current medicine shortages will be exacerbated as a result. Headline Expenditure Projections ? Pharmaceuticals: EUR2.17bn (US$2.75bn) in 2012 to EUR2.02bn (US$2.69bn) in 2013; -6.7 % in local currency terms and -2.2% in US dollar terms. Forecast … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=118158. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/ireland-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions